75
Participants
Start Date
October 31, 2022
Primary Completion Date
February 20, 2024
Study Completion Date
August 23, 2024
DISC-1459
Oral dose level 1, once a day for 120 days
DISC-1459
Oral dose level 2, once a day for 120 days
Placebo
Oral dose, once a day for 120 days
DISC-1459
Oral dose level 1, once a day for up to 8 months
Mount Sinai Hospital, New York
Einstein Medical Center, Philadelphia
Atrium Health Wake Forest Baptist, Winston-Salem
University of Miami Miller School of Medicine, Miami
University of Alabama Hospital, Birmingham
University of Texas, Galveston
University of California San Francisco, San Francisco
Fred Hutchinson Cancer Center, Seattle
Massachusetts General Hospital, Boston
Lead Sponsor
Disc Medicine, Inc
INDUSTRY